Micro-X Ltd
ASX:MX1
Micro-X Ltd
Revenue
Micro-X Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Micro-X Ltd
ASX:MX1
|
Revenue
AU$15.2m
|
CAGR 3-Years
19%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
Neurotech International Ltd
ASX:NTI
|
Revenue
AU$1.3m
|
CAGR 3-Years
148%
|
CAGR 5-Years
83%
|
CAGR 10-Years
N/A
|
|
ImpediMed Ltd
ASX:IPD
|
Revenue
AU$10.5m
|
CAGR 3-Years
17%
|
CAGR 5-Years
24%
|
CAGR 10-Years
13%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Revenue
AU$27.8m
|
CAGR 3-Years
24%
|
CAGR 5-Years
16%
|
CAGR 10-Years
9%
|
Cochlear Ltd
ASX:COH
|
Revenue
AU$2.1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Revenue
AU$7.1m
|
CAGR 3-Years
93%
|
CAGR 5-Years
70%
|
CAGR 10-Years
N/A
|
See Also
What is Micro-X Ltd's Revenue?
Revenue
15.2m
AUD
Based on the financial report for Dec 31, 2023, Micro-X Ltd's Revenue amounts to 15.2m AUD.
What is Micro-X Ltd's Revenue growth rate?
Revenue CAGR 5Y
25%
Over the last year, the Revenue growth was -10%. The average annual Revenue growth rates for Micro-X Ltd have been 19% over the past three years , 25% over the past five years .